DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV

Clinical trial NCT04433780 · COMPLETED

Trial details

NCT number: NCT04433780
Sponsor: Professor Francois Venter
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2021-01-04
Primary completion: 2023-02-20
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.